On the contrary, in patients with higher PSA levels, the higher tumor burden and the higher degree of PSMA tracer uptake increase the chance that disease localizations are also detected by analog scanners despite their lower sensitivity, thus resulting in a higher number of positive scans at aPET and a detection rate comparable to dPET. Here, KLK3 is linked to neoplasm.